For the third time in about two years, the FDA has cit­ed man­u­fac­tur­ing de­fi­cien­cies in re­ject­ing a drug com­bi­na­tion from Jiang­su Hen­grui Phar­ma­ceu­ti­cals and El­e­var...

The FDA on Fri­day post­ed 14 new re­jec­tion let­ters to phar­ma com­pa­nies on­line, days af­ter HHS con­firmed to End­points Newsthat the agency had paused...

The FDA's drug cen­ter hired more new em­ploy­ees than it lost in a quar­ter for the first time since the Trump ad­min­is­tra­tion gut­ted the agen­cy's...

Ja­nine Sen­gstack be­lieves she may have found the next big break­through in di­a­betes and obe­si­ty. Her com­pa­ny, Junevi­ty, has searchedthrough hun­dreds of genes to...

MON­TRE­AL— Af­ter No­vo Nordisk closed its cell ther­a­py unit, Cel­lu­lar In­tel­li­gence con­tract­ed neu­rol­o­gist and drug de­vel­op­er Nuno Men­donça to con­duct due dili­gence on the...